Imudon lozenges, No. 24

Treatment and / or prevention:

• superficial and deep periodontal disease, periodontitis, stomatitis, glossitis, aphthous stomatitis;

• inflammatory and infectious diseases of the oral cavity and pharynx;

• erythematous and ulcerative gingivitis;

• dysbiosis of the oral cavity;

• pharyngitis;

• chronic tonsillitis;

• ulceration caused by dentures;

• infections after tooth extraction, implantation of artificial dental roots;

• preoperative preparation for tonsillectomy;

• postoperative period after tonsillectomy.

Inside.

Adults and adolescents over 14 years old

For acute inflammatory diseases of the oral cavity and pharynx and exacerbation of chronic diseases: - 8 tab. in a day. Tablets dissolve (without chewing) in the oral cavity with an interval of 1 hour. The average duration of the course of treatment is 10 days.

For the prevention of chronic inflammatory diseases of the oral cavity and pharynx: 6 tab. in a day. The tablets dissolve (without chewing) in the oral cavity with an interval of 2 hours. The course duration is 20 days.

Children from 3 to 14 years old

In the treatment of acute and exacerbation of chronic inflammatory diseases of the oral cavity and pharynx, as well as for prevention: 6 tab. in a day. Tablets dissolve (without chewing) in the oral cavity with an interval of 2 hours. The duration of the course of treatment for acute diseases is 10 days, for the prevention of chronic diseases - 20 days.

It is recommended to carry out preventive courses of taking ImudonЃ 3-4 times a year.

Tablets for resorption, white or almost white, flat-cylindrical, with a smooth shiny surface, with beveled edges, with a mint smell, slight marbling is allowed.

1 tab.

mixture of bacterial lysates (ImudonЃ) (calculated on dry matter) 2.7 mg,

[Lactobacillus johnsonii, Lactobacillus helveticus, Lactobacillus delbrueckii ss lactis, Lactobacillus fermentum, Streptococcus pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Staphylococcus gordinii, Staphylococcus aureus, Klebsiella pneumoniae ss pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum ss fusiforme, Candida albicans] 0.1575 mg

Excipients: sodium deoxycholate - 0.53 mg, thiomersal - no more than 0.0125 mg, glycine - 49.3 mg, lactose monohydrate - 350 mg, mannitol - 100 mg, sodium saccharinate - 1.12 mg, povidone - 10 mg, sodium bicarbonate - 30 mg, lemon anhydrous acid - 23 mg, mint flavor - 8 mg, magnesium stearate - 4.88 mg.

• Increased individual sensitivity to the drug or its components;

• children's age up to 3 years;

• autoimmune diseases

Pharmacodynamics:

An immunostimulating drug of bacterial origin for local use in dentistry and otorhinolaryngology. Activates phagocytosis, increases the number of immunocompetent cells, increases the production of lysozyme, interferon and secretory immunoglobulin A in saliva.

Pharmacokinetics:

The drug primarily acts in the oral cavity

Overdose:

Overdose cases are not described

Influence on the ability to drive vehicles and mechanisms:

There is no evidence of the need for any restrictions on activities related to driving or other mechanisms during the treatment period.

Interaction with other medicinal products:

can be used with drugs of other groups

Special instructions:

Children from 3 to 6 years old dissolve tablets under the obligatory supervision of adults! Patients with bronchial asthma, in whom the intake of drugs containing bacterial lysates, causes an exacerbation of the disease (an attack of bronchial asthma), it is not recommended to use the drug

Side effects:

In rare cases: rash, urticaria, angioedema, nausea, vomiting, abdominal pain, fever, exacerbation of bronchial asthma, cough. In very rare cases: erythema nodosum, hemorrhagic vasculitis, thrombocytopenia